advertisement
11.4 Prostaglandins (14)
Showing records 1 to 14
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins57470 Effects of treatment with bimatoprost 0.03% for 3 years in patients with normal-tension glaucoma
Inoue K; Shiokawa M; Fujimoto T; Tomita G
Clinical Ophthalmology 2014; 8: 1179-1183
57254 Glaucoma prescribing trends in England 2000 to 2012
Connor AJ; Fraser SG
Eye 2014; 28: 863-869
57308 Contralateral intraocular pressure lowering effect of prostaglandin analogues
Rao HL; Senthil S; Garudadri CS
Indian Journal of Ophthalmology 2014; 62: 575-579
57022 Investigation of ocular events associated with taprenepag isopropyl, a topical EP2 agonist in development for treatment of glaucoma
Yanochko GM; Affolter T; Eighmy JJ; Evans MG; Khoh-Reiter S; Lee D; Miller PE; Shiue MH; Trajkovic D; Jessen BA
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 429-439
57051 Effects of long-term topical prostaglandin therapy on central corneal thickness
Maruyama Y; Mori K; Ikeda Y; Ueno M; Kinoshita S
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 440-444
57343 Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertension
Sanford M
Clinical Drug Investigation 2014; 34: 521-528
57126 Long-term 24-hour Intraocular Pressure Control With Travoprost Monotherapy in Patients With Primary Open-angle Glaucoma
Riva I; Katsanos A; Floriani I; Biagioli E; Konstas AG; Centofanti M; Quaranta L
Journal of Glaucoma 2014; 23: 535-540
57446 Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs
Schmier JK; Hulme-Lowe CK; Covert DW
Clinical Ophthalmology 2014; 8: 1097-1104
57273 Trans-conjunctival aqueous humor outflow in glaucomatous patients treated with prostaglandin analogues: an in vivo confocal microscopy study
Mastropasqua R; Fasanella V; Pedrotti E; Lanzini M; Di Staso S; Mastropasqua L; Agnifili L
Graefe's Archive for Clinical and Experimental Ophthalmology 2014; 252: 1469-1476
57348 Effects of Polyquaternium- and Benzalkonium-Chloride-Preserved Travoprost on Ocular Surfaces: An Impression Cytology Study
Sezgin Akçay BI; Güney E; Bozkurt TK; Topal CS; Akkan JC; Unlü C
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 548-553
57052 Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% versus concomitant use of the ingredients
Holló G; Hommer A; Antón López A; Ropo A
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 468-475
57517 Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension
Bhagat P; Sodimalla K; Paul C; Pandav SS; Raman GV; Ramakrishnan R; Joshi A; Raut A
Clinical Ophthalmology 2014; 8: 1241-1252
57374 Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension
Cheng YH; Hung KH; Tsai TH; Lee CJ; Ku RY; Chiu AW; Chiou SH; Liu CJ
Acta biomaterialia 2014; 10: 4360-4366
57511 Meta-analysis of randomized controlled trials comparing selective laser trabeculoplasty with prostaglandin analogue in the primary treatment of open-angle glaucoma or ocular hypertention
Peng W; Zhong X; Yu M
Chinese Journal of Ophthalmology 2014; 50: 343-348
